Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg-negative patients

被引：0
|
作者：
Chen, E-Q. [1 ]
Wang, M-L. [1 ]
Wu, D-B. [1 ]
Liao, J. [1 ]
Tang, H. [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Sichuan, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 48卷 / 02期
关键词：
CHRONIC HEPATITIS-B;
D O I：
10.1111/apt.14815
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：236 / 237
页数：2
相关论文
共 50 条
  • [41] Predictive role of serum HBsAg and HBcrAg levels in patients with HBeAg-negative chronic hepatitis B treated with pegylated interferon-based therapy
    Chuaypen, Natthaya
    Posuwan, Nawarat
    Payungporn, Sunchai
    Treeprasertsuk, Sombat
    Tanaka, Yasuhito
    Poovorawan, Yong
    Tangkijvanich, Pisit
    HEPATOLOGY, 2016, 64 : 908A - 909A
  • [42] Monitoring interferon and lamivudine treatment by quantitative measurement of HBsAg and HDV-RNA serum levels in HBeAg-negative patients with chronic hepatitis delta
    Manesis, Emanuel K.
    Schina, Maria
    Gault, Elyanne
    Agelopoulou, Olga
    Papaioannou, Christos
    Kalligeros, Konstantine
    Arseniou, Vaios
    Manolakolpoulos, Spilios
    Hadziyannis, Emilia S.
    Le Gal, Frederic
    Koskinas, John
    Papatheodoridis, George
    Archimandritis, Athanasios J.
    HEPATOLOGY, 2006, 44 (04) : 673A - 673A
  • [43] EARLY ON-TREATMENT HBSAG AND HBV DNA LEVELS IDENTIFY HBEAG-NEGATIVE PATIENTS NOT RESPONDING TO 48 OR 96 WEEKS OF PEGINTERFERON ALFA-2A THERAPY
    Rijckborst, Vincent
    Hansen, Bettina E.
    Ferenci, Peter
    Brunetto, Maurizio R.
    Tabak, Fehmi
    Cakaloglu, Yilmaz
    Lanza, Alfonso G.
    Messina, Vincenzo
    Iannacone, Claudio
    Massetto, Benedetto
    Martins, Eduardo B.
    Colombo, Massimo
    Janssen, Harry L.
    Lampertico, Pietro
    HEPATOLOGY, 2010, 52 (04) : 557A - 558A
  • [44] Clinical outcomes of treatment-naïve HBeAg-negative patients with chronic hepatitis B virus infection with low serum HBsAg and undetectable HBV DNA
    Wang, Jian
    Zhu, Li
    Zhang, Shaoqiu
    Zhang, Zhiyi
    Fan, Tao
    Cao, Fei
    Xiong, Ye
    Pan, Yifan
    Li, Yuanyuan
    Jiang, Chao
    Yin, Shengxia
    Tong, Xin
    Xiong, Yali
    Xia, Juan
    Yan, Xiaomin
    Liu, Yong
    Liu, Xingxiang
    Chen, Yuxin
    Li, Jie
    Zhu, Chuanwu
    Wu, Chao
    Huang, Rui
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [45] Longitudinal changes in serum HBV-DNA levels during the natural course of HBeAg-negative chronic hepatitis B virus (HBV) infection
    Papatheodoridis, G. V.
    Sevastianos, V.
    Panopoulou, H.
    Chrysanthos, N.
    Hadziyannis, E.
    Cholongitas, E.
    Laras, A.
    Manesis, E. K.
    Hadziyannis, S. J.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S182 - S182
  • [46] Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Chuaypen, Natthaya
    Sriprapun, Methee
    Praianantathavorn, Kesmanee
    Payungporn, Sunchai
    Wisedopas, Naruemon
    Poovorawan, Yong
    Tangkijvanich, Pisit
    JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (01) : 130 - 138
  • [47] Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Chuaypen, Natthaya
    Sriprapun, Methee
    Praianantathavorn, Kesmanee
    Payungporn, Sunchai
    Wisedopas, Naruemon
    Poovorawan, Yong
    Tangkijvanich, Pisit
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 373 - 373
  • [48] Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels
    Ormeci, Asli
    Aydin, Yucel
    Sumnu, Abdullah
    Baran, Bulent
    Soyer, Ozlem Mutluay
    Pinarbasi, Binnur
    Gokturk, Suut
    Gulluoglu, Mine
    Onel, Derya
    Badur, Selim
    Akyuz, Filiz
    Karaca, Cetin
    Demir, Kadir
    Besisik, Fatih
    Kaymakoglu, Sabahattin
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 52 : 68 - 73
  • [49] HBeAg-negative chronic hepatitis B (CHBE-) in chronic HBV patients with serum HBV-DNA levels below 2,000 IU/mL
    Papatheodoridis, G. V.
    Manesis, E. K.
    Manolakopoulos, S.
    Goulis, J.
    Chrysanthos, N.
    Bilalis, A.
    Savvidou, S.
    Kafiri, G.
    Delladetsima, I.
    Tzourmakliotis, D.
    Archimandritis, A. J.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S183 - S183
  • [50] Virus-Specific Immune Response in HBeAg-Negative Chronic Hepatitis B: Relationship with Clinical Profile and HBsAg Serum Levels
    Loggi, Elisabetta
    Bihl, Florian K.
    Cursaro, Carmela
    Granieri, Camilla
    Galli, Silvia
    Brodosi, Lucia
    Furlini, Giuliano
    Bernardi, Mauro
    Brander, Christian
    Andreone, Pietro
    PLOS ONE, 2013, 8 (06):
12345